longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Genocea Biosciences

GNCAQ

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q1 FY2022 Earnings

Financial report interval: 2021.12.31 - 2022.03.31

Overview: Genocea Biosciences(GNCAQ) the Revenue is 270 K (--%), Miss estimate;the EBIT is -15.77 M (-26.98%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.00B--
-0.00B--%
EBITMiss expectations
-0.02B26.98%
-0.01B2.10%
-0.00B24.88%

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf